Assessing the acceptability, affordability, and availability of teleoncology services among cancer patients: A cross-sectional study.

Abstract

With the increasing burden of cancer and the need for continuous patient monitoring, teleoncology has emerged as an innovative approach to improve healthcare delivery. However, its utilization in real-world settings, particularly in resource-limited regions, remains underexplored. This study aims to assess cancer patients' perceptions of teleoncology services, focusing on their acceptability, affordability, and accessibility. A cross-sectional hospital-based study was carried out in Jaipur, Rajasthan. This study was conducted from July 2024 to December 2024 using a semistructured questionnaire. Cancer patients utilizing teleoncology services for consultations, follow-ups, and disease monitoring were included. The <i>Service User Technology Acceptability Questionnaire (SUTAQ)</i> was used to measure acceptability. Data were analyzed for demographic variations and affordability perceptions. Collected data were analyzed (Descriptive and Inferential) using SPSS V.25. A total of 125 patients participated in the study, with a nearly equal gender distribution (50.79% male, 49.21% female). The mean age of male and female respondents was 48.27 ± 14.53 years and 43.17 ± 14.39 years, respectively. Acceptability: 77% of patients reported using teleoncology not just for cancer care but also for other health conditions. The mean satisfaction score was 4.2, indicating high acceptance. Affordability: There was no significant difference in perceptions of affordability across gender, geography, or age groups (<i>P</i> > 0.05). Patients found teleoncology cost-effective, with a mean affordability perception of 4.3 (agree to strongly agree). Availability: While 48.1% agreed that services were available 24/7, 38.4% disagreed, indicating gaps in accessibility. Specialist availability received a mean score of 3.6, reflecting moderate satisfaction. Teleoncology is widely accepted due to its convenience and affordability, but challenges remain regarding 24/7 service availability and digital literacy. A hybrid model integrating teleoncology with periodic in-person visits could enhance patient experience. Imminent research should focus on long-term outcomes and strategies to improve teleoncology adoption among underserved populations.